Cerebral Angiogenesis: A Realistic Therapy for Ischemic Disease
Angiogenesis, the sprouting of new capillaries from existing blood vessels, accompanies clinical and experimental stroke and is focused particularly in the salvageable ischemic border zone. As this endogenous angiogenic response correlates positively with clinical prognosis, a more complete understanding of the underlying molecular mechanisms and timing of these events may help in the design of novel therapies for vascular regeneration after stroke. In this review we discuss endogenous protective mechanisms, including angiogenesis and vasculogenesis, and underlying molecular mechanisms. We also consider the feasibility of angiogenic therapy for stroke and its optimal timing.
- Molecular Probes for PNS Neurotoxicity, Degeneration, and Regeneration
- Isolating and Culturing of Precursor Cells from the Adult Human Brain
- The Study of Membrane- or Receptor-Bound Neuropeptides by NMR
- Expression of m-Calpain in Escherichia coli
- Cranial Window Assessments in Experimental aSAH in Mice
- An Assay for Characterizing In Vitro the Kinetics of Polyglutamine Aggregation
- Homology-Based Cloning Methods: Identification of the NPY Y2, Y4, and Y6 Receptors
- Effects of Alpha-Synuclein Expression on Behavioral Activity in Drosophila : A Simple Model of Parkinsons Disease
- Measurement of Neuropeptides in Dialysate by LC-MS
- Mutant and Transgenic Zebrafish in Modeling Neurobehavioral Disorders